Mr. Rob Hill reports

EMERALD HEALTH THERAPEUTICS RECEIVES FIRST PURCHASE ORDER TO SUPPLY ITS CANNABIS PRODUCTS TO QUEBEC RECREATIONAL CANNABIS MARKET

Emerald Health Therapeutics Inc. has received its first purchase order from Societe Quebecoise du Cannabis (SQDC) to supply its cannabis products to the Quebec recreational cannabis market. Emerald is scheduled to fulfill its first shipment the week of June 3, 2019.

"We are pleased to have the opportunity to supply Quebec with our Emerald-branded cannabis products," said Dr. Avtar Dhillon, president and executive chairman of Emerald. "With $71-million in sales during the first six months of legalized recreational cannabis, the SQDC recorded the second-highest provincial sales in Canada, making it a significant market for Emerald to now offer our recreational cannabis products, as well as introduce our locally produced Verdelite-branded products in the months ahead."

Emerald is currently delivering cannabis to the Ontario Cannabis Retail Corp., Cannabis Retail Store, the British Columbia Liquor Distribution Board, the Newfoundland Labrador Liquor Corp., PEI Cannabis, the Yukon Liquor Corp. and to licensed private retailers in Saskatchewan. Emerald has also been authorized by the Manitoba Liquor & Lotteries Corp. to supply cannabis to Manitoba and signed a sales agreement with the Alberta Gaming, Liquor and Cannabis to supply cannabis to Alberta.

About Emerald Health Therapeutics Inc.

Emerald Health is a Canadian licensed producer of cannabis. Its 50-per-cent-owned Pure Sunfarms joint venture in British Columbia is licensed and fully planted in the first of its two 1.1-million-square-foot greenhouses. The capacity of each greenhouse is estimated to exceed 75,000 kilograms of cannabis annually. Emerald's Verdelite operation in Saint Eustache, Que., is completing the buildout of its 88,000-square-foot indoor cultivation facility and is scaling up production.

We seek Safe Harbor.